Fig. 1From: Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in ChinaIntraocular pressure (IOP) at different time points (baseline, 1Â week, 1Â month, and 3Â months) A All patients; B Group A; C Group B; D Group CBack to article page